Zero Candida Technologies, Inc. (FRA:9L2)

Market Cap	1.33M -59.8%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0500
Previous Close	0.0500
Day's Range	0.0490 - 0.0500
52-Week Range	0.0475 - 0.1520
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Zero Candida Technologies

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Eli Ben-Haroosh
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 9L2

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error